Supernus Pharmaceuticals (SUPN) Current Taxes: 2016-2020
Historic Current Taxes for Supernus Pharmaceuticals (SUPN) over the last 3 years, with Jun 2020 value amounting to $25.1 million.
- Supernus Pharmaceuticals' Current Taxes rose 836.87% to $25.1 million in Q2 2020 from the same period last year, while for Jun 2020 it was $25.1 million, marking a year-over-year increase of 836.87%. This contributed to the annual value of $2.4 million for FY2019, which is 80.26% down from last year.
- Per Supernus Pharmaceuticals' latest filing, its Current Taxes stood at $25.1 million for Q2 2020, which was up 175.39% from $9.1 million recorded in Q1 2020.
- Supernus Pharmaceuticals' 5-year Current Taxes high stood at $25.1 million for Q2 2020, and its period low was $7,000 during Q4 2016.
- For the 3-year period, Supernus Pharmaceuticals' Current Taxes averaged around $10.9 million, with its median value being $9.1 million (2020).
- Per our database at Business Quant, Supernus Pharmaceuticals' Current Taxes spiked by 227,585.71% in 2017 and then crashed by 80.26% in 2019.
- Over the past 5 years, Supernus Pharmaceuticals' Current Taxes (Quarterly) stood at $7,000 in 2016, then soared by 227,585.71% to $15.9 million in 2017, then fell by 22.34% to $12.4 million in 2018, then tumbled by 80.26% to $2.4 million in 2019, then skyrocketed by 836.87% to $25.1 million in 2020.
- Its Current Taxes was $25.1 million in Q2 2020, compared to $9.1 million in Q1 2020 and $2.4 million in Q4 2019.